Summary
Background
Ankaferd blood stopper (ABS) is a herbal extract that enhances mucosal healing. It has therapeutic potential in the management of external hemorrhage and controlling gastrointestinal bleeding associated with various benign lesions refractory to conventional antihemorrhagic measures. The aim of this experimental study was to assess the effects of ABS on hemorrhagic lesions and compare them with omeprazole.
Methods
The study was conducted on 30 rats. Rats were divided into five groups: group A (only indomethacin), group B (ABS administration 60 min before indomethacin-induced injury), group C (ABS administration 30 min after indomethacin-induced injury), group D (omeprazole administration 60 min before indomethacin‐induced injury), group E (omeprazole administration 30 min after indomethacin‐induced injury). Gastric mucosal lesions were produced by indomethacin in all three groups. The effect was studied morphologically 6 h after oral administration of the drug. Subsequently, affected tissue was examined histologically.
Results
Based on the number and the total size of hemorrhagic lesions, the hemorrhagic lesion scores were significantly better in Group C compared to other groups (p < 0.05). The hemorrhagic lesion score of Group B was significantly better than Group D and Group A (p < 0.05). Omeprazole groups (Group D, Group E) did not show significant improvement as indicated by macroscopic scores. There was no significant difference between the groups with respect to microscopic scores.
Conclusion
These results indicate that ABS has a potent inhibitory action on indomethacin-induced gastric bleeding and mucosal lesions and it is useful in the treatment of acute gastric mucosal lesions.
Similar content being viewed by others
References
Beyazit Y, Kurt M, Kekilli M, Goker H, Haznedaroglu IC. Evaluation of hemostatic effects of Ankaferd as an alternative medicine. Altern Med Rev. 2010 Dec;15(4):329–36. Review.
Göker H, Haznedaroglu IC, Erçetin S, Kirazlı S, Akman U, Öztürk Y, Fırat HC. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res. 2008;36:163–70.
Haznedaroglu BZ, Haznedaroglu IC, Walker SL, et al. Ultrastructural and morphological analyses of the in vitro and in vivo hemostatic effects of Ankaferd Blood Stopper. Clin Appl Thromb Hemost. 2010;16:446–53.
Al B, Yildirim C, Cavdar M, et al. Effectiveness of Ankaferd Blood Stopper in the topical control of active bleeding due to cutaneous-subcutaneous incisions. Saudi Med J. 2009;30:1520–5.
Teker AM, Korkut AY, Gedikli O, Kahya V. Prospective, controlled clinical trial of Ankaferd Blood Stopper in children undergoing tonsillectomy. Int J Pediatr Otorhinolaryngol. 2009;73:1742–5.
Meric Teker A, Korkut AY, Kahya V, Gedikli O. Prospective randomized, controlled clinical trial of Ankaferd Blood Stopper in patients with acute anterior epistaxis. Eur Arch Otorhinolaryngol. 2010;267:1377–81.
Kurt M, Kacar S, Onal IK, et al. Ankaferd Blood Stopper as an effective adjunctive hemostatic agent for the management of life-threatening arterial bleeding of the digestive tract. Endoscopy. 2008;40:E262.
Kurt M, Akdogan M, Onal IK, et al. Endoscopic topical application of Ankaferd Blood Stopper for neoplastic gastrointestinal bleeding: a retrospective analysis. Dig Liver Dis. 2010;42:196–9.
Koçak E, Akbal E, Taş A, Köklü S, Karaca G, Can M, Kösem B, Üstün H. Anti-inflammatory efficiency of Ankaferd blood stopper in experimental distal colitis model. Saudi J Gastroenterol. 2013 May–Jun;19(3):126–30.
Beyazit Y, Köklü S, Akbal E, Kurt M, Kekilli M, Haznedaroglu IC. Successful treatment of endoscopic sphincterotomy-induced early hemorrhage with application of Ankaferd Blood Stopper. Gastrointest Endosc. 2010 Dec;72(6):1325–6.
Ozaslan E, Purnak T, Yildiz A, Haznedaroglu IC. The effect of a new hemostatic agent for difficult cases of non-variceal gastrointestinal bleeding: Ankaferd Blood Stopper. Hepatogastroenterology. 2010;57:191–4.
Arslan S, Oz B, Haznedaroglu IC, Goker H. Endobronchial application of Ankaferd Blood Stopper to control profuse lung bleeding leading to hypoxemia and hemodynamic instability. Respir Med CME. 2009;2:144–6.
Dogan OF, Ozyurda U, Uymaz OK, et al. New anticoagulant agent for CABG surgery. Eur J Clin Invest. 2008;38:341.
Akbal E, Köklü S, Astarcı HM, Koçak E, Karaca G, Beyazıt Y, Topcu G, Acar B, Ergün D, Haznedaroğlu İC. Oral high-dose ankaferd administration effects on gastrointestinal system. Int J Med Sci. 2013;10(4):451–6
Akbal E, Köklü S, Karaca G, Astarcı HM, Koçak E, Taş A, Beyazıt Y, Haznedaroğlu İ. Beneficial effects of Ankaferd Blood Stopper on caustic esophageal injuries: an experimental model. Dis Esophagus. 2012 Apr;25(3):188–94. doi: 10.1111/j.1442-2050.2011.01231.x. Epub 2011 Aug 5.
Ibis M, Kurt M, Onal IK, Haznedaroglu IC. Successful management of bleeding due to solitary rectal ulcer via topical application of Ankaferd Blood Stopper. J Altern Complement Med. 2008;14:1073–4.
Ozaslan E, Purnak T, Haznedaroglu IC. Ankaferd Blood Stopper in GI bleeding: alternative for everything? Gastrointest Endosc. 2011 Jan;73(1):185–6; author reply 186–7.
Okten S, Kurt M, Onal IK, Haznedaroglu IC. Use of Ankaferd Blood Stopper for controlling actively bleeding fundal varices. Singapore Med J. 2011 Jan; 52(1):e11–2.
Ozaslan E, Purnak T, Ozyigit G, Akyol F, Yildiz A, Haznedaroglu IC. No prolonged effect of Ankaferd Blood Stopper on chronic radiation proctitis. Endoscopy. 2010;42Suppl 2:E271–2. Epub 2010 Oct 7.
Karaman K, Bostanci EB, Ercan M, Kurt M, Teke Z, Reyhan E, Akoglu M. Topical Ankaferd application to presacral bleeding due to total mesorectal excision in rectal carcinoma. J Invest Surg. 2010 Jun;23(3):175.
Purnak T, Ozaslan E, Beyazit Y, Haznedaroglu IC. Upper gastrointestinal bleeding in a patient with defective hemostasis successfully treated with ankaferd blood stopper. Phytother Res. 2011 Feb;25(2):312–3. doi: 10.1002/ptr.3252.
Murakami M, Saita H, Teramura S, Gastric ammonia has a potent ulcerogenic action on the rat stomach. Gastroenterology 1993;105:1710–5.
Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–81.
Toapanta-Yanchapaxi L, Chavez-Tapia N, Téllez-Ávila F. Cyanoacrylate spray as treatment in difficult-to-manage gastrointestinal bleeding. World J Gastrointest Endosc. 2014 Sep 16;6(9):448–52.
Ozaslan E, Purnak T, Yildiz A, Haznedaroglu IC. Bleeding due to slippage of elastic band during variceal ligation: successful use of Ankaferd blood stopper. Indian J Gastroenterol. 2010 Jul;29(4):166–8. Epub 2010 Sep 3.
Tuncer I, Doganay L, Ozturk O. Instant control of fundal variceal bleeding with a folkloric medicinal plant extract: Ankaferd Blood Stopper. Gastrointest Endosc. 2010 Apr;71(4):873–5. Epub 2009 Nov 17
Zulfikar OB, Emiroglu HH, Kebudi R. Nasogastric application of topical Ankaferd Blood Stopper for bleeding from primary esophageal adenocarcinoma in a child with disseminated intravascular coagulation. Dig Liver Dis. 2011 Mar;43(3):247–8. Epub 2010 Dec 21
Ozaslan E, Purnak T, Yildiz A, Haznedaroglu IC. A new practical alternative for tumoural gastrointestinal bleeding: Ankaferd blood stopper. Dig Liver Dis. 2010 Aug;42(8):594–5. Epub 2009 Dec 11.
Shorbagi A, Sivri B. Successful management of a difficult case of radiation proctopathy with Ankaferd Blood Stopper: a novel indication (with video). Gastrointest Endosc. 2010;72:666–7.
Taş A, Köklü S, Beyazit Y, Karaca G, Astarcı HM, Akbal E, Koçak E, Topçu G, Haznedaroglu IC. Percutaneous ankaferd injection to in vivo liver tissue in comparison to ethanol in an experimental rat model. Clin Res Hepatol Gastroenterol. 2011 Sep;35(8–9):549–53.
Kosar A, Cipil HS, Kaya A, et al. The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model. Blood Coagul Fibrinolysis. 2009;20:185–90.
Ergenoglu MU, Yerebakan H, Kucukaksu DS. A new practical alternative for the control of sternal bleeding during cardiac surgery: Ankaferd Blood Stopper. Heart Surg Forum. 2010 Dec 1;13(6):E379–80.
Kılıçgün A, Sarıkaş NG, Korkmaz T, Saydam O, Boran C, Boztaş G. Effect of Ankaferd Blood Stopper on air leakage in the lung and prevention of bleeding: an experimental study. J Cardiothorac Surg. 2011 Feb 27;6:20.
İşler SC, Demircan S, Cakarer S, et al. Effects of folk medicinal plant extract Ankaferd Blood Stopper on early bone healing. J Appl Oral Sci. 2010;18:409–14.
Cipil HS, Kosar A, Kaya A, et al. In vivo hemostatic effect of the medicinal plant extract Ankaferd Blood Stopper in rats pretreated with warfarin. Clin Appl Thromb Hemost. 2009;15:270–6.
Huri E, Haznedaroglu IC, Akgul T, Astarci M, Ustun H, Germiyanoulu C. Biphasic effects of ankaferd blood stopper on renal tubular apoptosis in the rat partial nephrectomy model representing distinct levels of hemorrhage. Saudi Med J. 2010 Aug;30(8):864–8.
Ergenoglu MU, Yerebakan H, Kucukaksu DS. A new practical alternative for the control of sternal bleeding during cardiac surgery: Ankaferd Blood Stopper. Heart Surg Forum. 2010 Dec 1;13(6):E379–80.
Beyazit Y, Onder FO, Torun S, Tas A, Purnak T, Tenlik I, Turhan N. Topical application of ankaferd hemostat in a patient with gastroduodenal amyloidosis complicated with gastrointestinal bleeding. Blood Coagul Fibrinolysis. 2013 Oct;24(7):762–5.
Ercetin S, Haznedaroglu IC, Kurt M, et al. Safety and efficacy of Ankaferd Blood Stopper in dental surgery. UHOD. 2010;20:1–5.
Conflict of interest
No commercial party having a direct financial support, any conflicts of interest in the results of the research supporting this article has or will confer a benefit on the authors or on any organization with which the authors are associated. The authors declare that there are no actual or potential conflicts of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Batgi, H., Akbal, E., Koçak, E. et al. Treatment of hemorrhagic gastritis by Ankaferd blood stopper versus Omeprazole: experimental randomized rat models. Wien Klin Wochenschr 128 (Suppl 8), 559–565 (2016). https://doi.org/10.1007/s00508-015-0762-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00508-015-0762-2